Market Overview:
The global pregnancy point of care testing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of infertility, rising awareness about early diagnosis and treatment of infertility, and technological advancements in POC testing devices. Based on type, the global pregnancy point of care testing market is segmented into LH urine test, FSH urine test, HCG blood test, and HCG urine test. The LH urine test segment is expected to account for the largest share in terms of revenue in 2018 owing to its high adoption rate across pharmacies & drugstores and gynecology & fertility clinics. Based on application, the market is segmented into pharmacies & drugstores, gynecology & fertility clinics hypermarkets & supermarkets, online sales channels), and others (hospitals/clinics). The pharmacies & drugstores segment accounted for the largest share in terms of revenue in 2017 due to rising demand for POC tests from consumers for early diagnosis and treatment options.
Product Definition:
Pregnancy Point of Care Testing is a comprehensive test that can be used to detect pregnancy as early as six days after ovulation. The test is performed by taking a urine sample and detecting the presence of human chorionic gonadotropin (hCG), the hormone produced by the placenta. Pregnancy Point of Care Testing is an important tool for confirming early pregnancies, especially in cases where traditional methods, such as home pregnancy tests or pelvic exams, are not conclusive.
LH Urine Test:
Luteinizing Hormone Urine Test (LHUT) is used to diagnose diabetes, hypogonadism, and hyperthyroidism. It also helps in monitoring the effects of certain drugs. The test works by measuring the amount of a hormone present in urine known as luteinizing hormone which is responsible for triggering the release of ovulation stimulating hormones from the pituitary gland.
FSH Urine Test:
FSH (Follicle Stimulating Hormone) is a protein produced by the anterior pituitary gland in response to stimulation from luteinizing hormone (LH). FSH stimulates the production of estrogen and testosterone as well as helps maintain cholesterol levels. It also regulates thyroid function, growth rate, and development of fetus during pregnancy.
Application Insights:
Based on application, the global market is segmented into pharmacies and drugstores, gynecology and fertility clinics, hypermarkets and supermarkets, online sales. The pharmacies and drug stores segment dominated the overall market in terms of revenue in 2017. This is attributed to factors such as rising awareness about available options for pregnancy testing among womenfolk as well as men's health concerns regarding this subject matter. Moreover, increasing availability of advanced point of care tests that are easy to use has also contributed positively towards this segment growth over the past few years.
The online sales segment is expected to grow at a rapid pace during the forecast period owing to growing internet penetration coupled with high consumer affinity towards purchasing products through internet portals due to various benefits offered by them including convenience along with savings on shipping charges etc., which further encourages consumers buying multiple items through single order transaction via net banking or credit/debit cards etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to rising awareness about early diagnosis of pregnancy, increasing prevalence of chronic diseases during pregnancy, and availability of advanced products for home testing kits. Moreover, presence of major players such as Abbott Laboratories; Bio-Rad Laboratories; CVS Pharmacy; and Amazon Web Services, Inc. has fueled the growth in this region.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as growing population with unmet needs regarding maternal health care facilities along with rising incidence rate of lifestyle-related disorders that lead to infertility or sub fertility conditions which are responsible for delay or prevent conception leading to low birth weight baby also called preterm births (PTB).
Growth Factors:
- Increasing incidence of pregnancy-related complications: The global prevalence of pregnancy-related complications is increasing at an alarming rate. This is primarily owing to the changing lifestyles and dietary habits of people across the world. Pregnancy Point of Care Testing helps in early diagnosis and treatment of these complications, thus improving the health outcomes for both mother and child.
- Growing demand for non-invasive prenatal tests: Non-invasive prenatal tests (NIPT) are becoming increasingly popular due to their high accuracy and safety profile. NIPT can be used to detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome in a fetus with a high degree of accuracy. This is driving demand for POC testing devices that offer NIPT capabilities.
- Rising awareness about preterm birth prevention: Preterm birth is one of the leading causes of infant mortality around the world. There is growing awareness among pregnant women about the importance of preterm birth prevention measures such as regular checkups, diet modification, etc., which is fueling demand for POC testing devices that can help in early detection/preventionof preterm births..
Scope Of The Report
Report Attributes
Report Details
Report Title
Pregnancy Point of Care Testing Market Research Report
By Type
LH Urine Test, FSH Urine Test, HCG Blood Test, HCG Urine Test
By Application
Pharmacies & Drugstores, Gynecology & Fertility Clinics, Hypermarkets & Supermarkets, Online Sales
By Companies
Swiss Precision Diagnostics, bioMerieux, Church & Dwight, Rohto, NFI Consumer Healthcare, Wondfo, Egens Biotech, Arax, Quidel Corporation, Runbio Biotech, Easy Healthcare, CIGA Healthcare, Biosynex, NOW Diagnostics, NG Biotech, Ulti med Products, EKF Diagnostics Holdings
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Pregnancy Point of Care Testing Market Report Segments:
The global Pregnancy Point of Care Testing market is segmented on the basis of:
Types
LH Urine Test, FSH Urine Test, HCG Blood Test, HCG Urine Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmacies & Drugstores, Gynecology & Fertility Clinics, Hypermarkets & Supermarkets, Online Sales
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Swiss Precision Diagnostics
- bioMerieux
- Church & Dwight
- Rohto
- NFI Consumer Healthcare
- Wondfo
- Egens Biotech
- Arax
- Quidel Corporation
- Runbio Biotech
- Easy Healthcare
- CIGA Healthcare
- Biosynex
- NOW Diagnostics
- NG Biotech
- Ulti med Products
- EKF Diagnostics Holdings
Highlights of The Pregnancy Point of Care Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- LH Urine Test
- FSH Urine Test
- HCG Blood Test
- HCG Urine Test
- By Application:
- Pharmacies & Drugstores
- Gynecology & Fertility Clinics
- Hypermarkets & Supermarkets
- Online Sales
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pregnancy Point of Care Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pregnancy Point of Care Testing is a new way to screen for pregnancy that uses a urine sample.
Some of the major players in the pregnancy point of care testing market are Swiss Precision Diagnostics, bioMerieux, Church & Dwight, Rohto, NFI Consumer Healthcare, Wondfo, Egens Biotech, Arax, Quidel Corporation, Runbio Biotech, Easy Healthcare, CIGA Healthcare, Biosynex, NOW Diagnostics, NG Biotech, Ulti med Products, EKF Diagnostics Holdings.
The pregnancy point of care testing market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pregnancy Point of Care Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pregnancy Point of Care Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pregnancy Point of Care Testing Market - Supply Chain
4.5. Global Pregnancy Point of Care Testing Market Forecast
4.5.1. Pregnancy Point of Care Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pregnancy Point of Care Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pregnancy Point of Care Testing Market Absolute $ Opportunity
5. Global Pregnancy Point of Care Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pregnancy Point of Care Testing Market Size and Volume Forecast by Type
5.3.1. LH Urine Test
5.3.2. FSH Urine Test
5.3.3. HCG Blood Test
5.3.4. HCG Urine Test
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pregnancy Point of Care Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pregnancy Point of Care Testing Market Size and Volume Forecast by Application
6.3.1. Pharmacies & Drugstores
6.3.2. Gynecology & Fertility Clinics
6.3.3. Hypermarkets & Supermarkets
6.3.4. Online Sales
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pregnancy Point of Care Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pregnancy Point of Care Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pregnancy Point of Care Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pregnancy Point of Care Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pregnancy Point of Care Testing Demand Share Forecast, 2019-2026
9. North America Pregnancy Point of Care Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pregnancy Point of Care Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pregnancy Point of Care Testing Market Size and Volume Forecast by Application
9.4.1. Pharmacies & Drugstores
9.4.2. Gynecology & Fertility Clinics
9.4.3. Hypermarkets & Supermarkets
9.4.4. Online Sales
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pregnancy Point of Care Testing Market Size and Volume Forecast by Type
9.7.1. LH Urine Test
9.7.2. FSH Urine Test
9.7.3. HCG Blood Test
9.7.4. HCG Urine Test
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pregnancy Point of Care Testing Demand Share Forecast, 2019-2026
10. Latin America Pregnancy Point of Care Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pregnancy Point of Care Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pregnancy Point of Care Testing Market Size and Volume Forecast by Application
10.4.1. Pharmacies & Drugstores
10.4.2. Gynecology & Fertility Clinics
10.4.3. Hypermarkets & Supermarkets
10.4.4. Online Sales
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pregnancy Point of Care Testing Market Size and Volume Forecast by Type
10.7.1. LH Urine Test
10.7.2. FSH Urine Test
10.7.3. HCG Blood Test
10.7.4. HCG Urine Test
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pregnancy Point of Care Testing Demand Share Forecast, 2019-2026
11. Europe Pregnancy Point of Care Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pregnancy Point of Care Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pregnancy Point of Care Testing Market Size and Volume Forecast by Application
11.4.1. Pharmacies & Drugstores
11.4.2. Gynecology & Fertility Clinics
11.4.3. Hypermarkets & Supermarkets
11.4.4. Online Sales
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pregnancy Point of Care Testing Market Size and Volume Forecast by Type
11.7.1. LH Urine Test
11.7.2. FSH Urine Test
11.7.3. HCG Blood Test
11.7.4. HCG Urine Test
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pregnancy Point of Care Testing Demand Share, 2019-2026
12. Asia Pacific Pregnancy Point of Care Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pregnancy Point of Care Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pregnancy Point of Care Testing Market Size and Volume Forecast by Application
12.4.1. Pharmacies & Drugstores
12.4.2. Gynecology & Fertility Clinics
12.4.3. Hypermarkets & Supermarkets
12.4.4. Online Sales
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pregnancy Point of Care Testing Market Size and Volume Forecast by Type
12.7.1. LH Urine Test
12.7.2. FSH Urine Test
12.7.3. HCG Blood Test
12.7.4. HCG Urine Test
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pregnancy Point of Care Testing Demand Share, 2019-2026
13. Middle East & Africa Pregnancy Point of Care Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pregnancy Point of Care Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pregnancy Point of Care Testing Market Size and Volume Forecast by Application
13.4.1. Pharmacies & Drugstores
13.4.2. Gynecology & Fertility Clinics
13.4.3. Hypermarkets & Supermarkets
13.4.4. Online Sales
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pregnancy Point of Care Testing Market Size and Volume Forecast by Type
13.7.1. LH Urine Test
13.7.2. FSH Urine Test
13.7.3. HCG Blood Test
13.7.4. HCG Urine Test
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pregnancy Point of Care Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pregnancy Point of Care Testing Market: Market Share Analysis
14.2. Pregnancy Point of Care Testing Distributors and Customers
14.3. Pregnancy Point of Care Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Swiss Precision Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. bioMerieux
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Church & Dwight
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Rohto
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. NFI Consumer Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Wondfo
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Egens Biotech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Arax
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Quidel Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Runbio Biotech
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Easy Healthcare
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. CIGA Healthcare
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Biosynex
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. NOW Diagnostics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. NG Biotech
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Ulti med Products
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. EKF Diagnostics Holdings
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
